Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease

Tuberculosis

Volumn 95, Issue 2, 2015, Pages 179-185

  Nikolayevskyy, Vladyslav ^a,g   Miotto, Paolo ^b   Pimkina, Edita ^c   Balabanova, Yanina ^a,g,h   Kontsevaya, Irina ^d   Ignatyeva, Olga ^d   Ambrosi, Alessandro ^e   Skenders, Girts ^f   Ambrozaitis, Arvydas ^c   Kovalyov, Alexander ^d   Sadykhova, Anna ^d   Simak, Tatiana ^d   Kritsky, Andrey ^d   Mironova, Svetlana ^d   Tikhonova, Olesya ^d   Dubrovskaya, Yulia ^d   Rodionova, Yulia ^d   Cirillo, Daniela ^b   Drobniewski, Francis ^a,g  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c VILNIUS UNIVERSITY   (Lithuania)

^d Samara TB Service   (Russian Federation)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Biomarkers; Laboratory diagnosis; Tuberculosis; Viability assays

Indexed keywords

ACETYLCYSTEINE; AZIDE; PROPIDIUM IODIDE; PROPIDIUM MONOAZIDE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASSAY; BACTERIUM CULTURE; CHEMOTHERAPY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPIDIUM MONOAZIDE VIABILITY ASSAY; SENSITIVITY AND SPECIFICITY; SPUTUM; ANALOGS AND DERIVATIVES; BACTERIAL LOAD; CLINICAL TRIAL; DRUG EFFECTS; DRUG MONITORING; EVALUATION STUDY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MICROBIAL VIABILITY; MICROBIOLOGY; MULTICENTER STUDY; PROCEDURES; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; ANTITUBERCULAR AGENTS; AZIDES; BACTERIAL LOAD; DRUG MONITORING; HUMANS; MICROBIAL VIABILITY; MYCOBACTERIUM TUBERCULOSIS; PROPIDIUM; SPECIMEN HANDLING; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84924959109     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2014.11.005     Document Type: Article

References (43)

1. WHO Global tuberculosis report 2012. WHO document WHO/HTM/TB/2012.6 2012 Geneva
2. D.I. Ling, L.L. Flores, L.W. Riley, and M. Pai Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression PloS One 3 2 2008 e1536
3. F. Drobniewski, V. Nikolayevskyy, H. Maxeiner, Y. Balabanova, N. Casali, I. Konsevaya, and O. Ignatyeva Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation BMC Med Aug 29 2013 11:190
4. F. Drobniewski, V. Nikolayevskyy, Y. Balabanova, D. Bang, and D. Papaventsis Diagnosis of tuberculosis and drug resistance: what can new tools bring us? Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 16 7 2012 860 870
5. R.S. Wallis, M. Pai, D. Menzies, T.M. Doherty, G. Walzl, M.D. Perkins, and A. Zumla Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice Lancet 375 9729 2010 1920 1937
6. L. Li, C.S. Mahan, M. Palaci, L. Horter, L. Loeffelholz, J.L. Johnson, R. Dietze, S.M. Debanne, M.L. Joloba, and A. Okwera Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy J Clin Microbiol 48 1 2010 46 51
7. L.E. Desjardin, M.D. Perkins, K. Wolski, S. Haun, L. Teixeira, Y. Chen, J.L. Johnson, J.J. Ellner, R. Dietze, and J. Bates Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy Am J Respir Crit Care Med 160 1 1999 203 210
8. P. Miotto, S. Bigoni, G.B. Migliori, A. Matteelli, and D.M. Cirillo Early tuberculosis treatment monitoring by Xpert(R) MTB/RIF Eur Respir J 39 5 2012 1269 1271
9. S. Mironova, E. Pimkina, I. Kontsevaya, V. Nikolayevskyy, Y. Balabanova, G. Skenders, T. Kummik, and F. Drobniewski Performance of the GenoType((R)) MTBDRPlus assay in routine settings: a multicenter study Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 2011
10. M.B. Miller, E.B. Popowitch, M.G. Backlund, and E.P. Ager Performance of Xpert MTB/RIF RUO assay and IS6110 real-time PCR for Mycobacterium tuberculosis detection in clinical samples J Clin Microbiol 49 10 2011 3458 3462
11. N. Mdivani, H. Li, M. Akhalaia, M. Gegia, L. Goginashvili, D.S. Kernodle, G. Khechinashvili, and Y.W. Tang Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum Clin Chem 55 9 2009 1694 1700
12. R. Gayathri, K.L. Therese, R. Sridhar, D. Kannan, H. Madhavan, and N. Meenakshi Rapid detection of viable M. tuberculosis directly from sputum by reverse transcriptase PCR targeting 85B gene J Commun Dis 43 2 2011 89 96
13. M. Fittipaldi, A. Nocker, and F. Codony Progress in understanding preferential detection of live cells using viability dyes in combination with DNA amplification J Microbiol Methods 91 2 2012 276 289
14. F. Hammes, M. Berney, and T. Egli Cultivation-independent assessment of bacterial viability Adv Biochem Eng/Biotechnol 124 2011 123 150
15. M.C. Riedy, K.A. Muirhead, C.P. Jensen, and C.C. Stewart Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations Cytometry 12 2 1991 133 139
16. H.K. Nogva, S.M. Dromtorp, H. Nissen, and K. Rudi Ethidium monoazide for DNA-based differentiation of viable and dead bacteria by 5'-nuclease PCR BioTechniques 34 4 2003 804 808 810, 812-803
17. A. Nocker, C.Y. Cheung, and A.K. Camper Comparison of propidium monoazide with ethidium monoazide for differentiation of live vs. dead bacteria by selective removal of DNA from dead cells J Microbiol Methods 67 2 2006 310 320
18. P. Kralik, A. Nocker, and I. Pavlik Mycobacterium avium subsp. paratuberculosis viability determination using F57 quantitative PCR in combination with propidium monoazide treatment Int J Food Microbiol 1 141 Suppl. 2010 S80 S86
19. T. Lovdal, M.B. Hovda, B. Bjorkblom, and S.G. Moller Propidium monoazide combined with real-time quantitative PCR underestimates heat-killed Listeria innocua J Microbiol Methods 85 2 2011 164 169
20. S. Wang, and R.E. Levin Discrimination of viable Vibrio vulnificus cells from dead cells in real-time PCR J Microbiol Methods 64 1 2006 1 8
21. G. Agusti, F. Codony, M. Fittipaldi, B. Adrados, and J. Morato Viability determination of Helicobacter pylori using propidium monoazide quantitative PCR Helicobacter 15 5 2010 473 476
22. A. Yasunaga, A. Yoshida, K. Morikawa, K. Maki, S. Nakamura, I. Soh, S. Awano, and T. Ansai Monitoring the prevalence of viable and dead cariogenic bacteria in oral specimens and in vitro biofilms by qPCR combined with propidium monoazide BMC Microbiol 13 2013 157
23. E. Pacholewicz, A. Swart, L.J. Lipman, J.A. Wagenaar, A.H. Havelaar, and B. Duim Propidium monoazide does not fully inhibit the detection of dead Campylobacter on broiler chicken carcasses by qPCR J Microbiol Methods 95 1 2013 32 38
24. H.L.V.D.A. Rieder, and K.M. Kam Priorities for tuberculosis bacteriology services in low-income countries 2nd ed. 2007 International Union Against Tuberculosis and Lung Disease Paris
25. S. Mocellin, A. Ambrosi, M.C. Montesco, M. Foletto, G. Zavagno, D. Nitti, M. Lise, and C.R. Rossi Support vector machine learning model for the prediction of sentinel node status in patients with cutaneous melanoma Ann Surg Oncol 13 8 2006 1113 1122
26. R.T. Trevor Hastie, and Jerome Friedman The elements of statistical learning: data mining, inference, and prediction 2009 Springer
27. R.S. Wallis, C. Wang, T.M. Doherty, P. Onyebujoh, M. Vahedi, H. Laang, O. Olesen, S. Parida, and A. Zumla Biomarkers for tuberculosis disease activity, cure, and relapse Lancet Infect Dis 10 2 2010 68 69
28. D. Benator, M. Bhattacharya, L. Bozeman, W. Burman, A. Cantazaro, R. Chaisson, F. Gordin, C.R. Horsburgh, J. Horton, and A. Khan Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial Lancet 360 9332 2002 528 534
29. M.D. Epstein, N.W. Schluger, A.L. Davidow, S. Bonk, W.N. Rom, and B. Hanna Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis Chest 113 2 1998 379 386
30. D. Seinige, C. Krischek, G. Klein, and C. Kehrenberg Comparative analysis and limitations of ethidium monoazide and propidium monoazide treatments for the differentiation of viable and nonviable campylobacter cells Appl Environ Microbiol 80 7 2014 2186 2192
31. J. Fujimoto, and K. Watanabe Quantitative detection of viable Bifidobacterium bifidum BF-1 cells in human feces by using propidium monoazide and strain-specific primers Appl Environ Microbiol 79 7 2013 2182 2188
32. B. Chang, T. Taguri, K. Sugiyama, J. Amemura-Maekawa, F. Kura, and H. Watanabe Comparison of ethidium monoazide and propidium monoazide for the selective detection of viable Legionella cells Jpn J Infect Dis 63 2 2010 119 123
33. Y. Pan, and F. Breidt Jr. Enumeration of viable Listeria monocytogenes cells by real-time PCR with propidium monoazide and ethidium monoazide in the presence of dead cells Appl Environ Microbiol 73 24 2007 8028 8031
34. A. Crespo-Sempere, N. Estiarte, S. Marin, V. Sanchis, and A.J. Ramos Propidium monoazide combined with real-time quantitative PCR to quantify viable Alternaria spp. contamination in tomato products Int J Food Microbiol 165 3 2013 214 220
35. V. Nikolayevskyy, Y. Balabanova, T. Simak, N. Malomanova, I. Fedorin, and F. Drobniewski Performance of the Genotype(R) MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation BMC Clin Pathol 9 2009 2
36. C.C. Boehme, P. Nabeta, D. Hillemann, M.P. Nicol, S. Shenai, F. Krapp, J. Allen, R. Tahirli, R. Blakemore, and R. Rustomjee Rapid molecular detection of tuberculosis and rifampin resistance N Engl J Med 363 11 2010 1005 1015
37. C.C. Boehme, M.P. Nicol, P. Nabeta, J.S. Michael, E. Gotuzzo, R. Tahirli, M.T. Gler, R. Blakemore, W. Worodria, and C. Gray Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study Lancet 377 9776 2011 1495 1505
38. N. Gous, B. Cunningham, B. Kana, W. Stevens, and L.E. Scott Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa J Clin Microbiol 51 12 2013 4018 4021
39. Report. Performance of Xpert MTB/RIF Version G4 assay. FIND, 2011, available at: (http://www.stoptb.org/wg/gli/assets/documents/map/findg4cartridge.pdf).
40. H. Kobayashi, M. Oethinger, M.J. Tuohy, G.S. Hall, and T.W. Bauer Distinction between intact and antibiotic-inactivated bacteria by real-time PCR after treatment with propidium monoazide J Orthop Res Off Publ Orthop Res Soc 28 9 2010 1245 1251
41. G.V. Mukamolova, O. Turapov, J. Malkin, G. Woltmann, and M.R. Barer Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum Am J Respir Crit Care Med 181 2 2010 174 180
42. R. Rustomjee, C. Lienhardt, T. Kanyok, G.R. Davies, J. Levin, T. Mthiyane, C. Reddy, A.W. Sturm, F.A. Sirgel, and J. Allen A phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 12 2 2008 128 138
43. N.J. Garton, S.J. Waddell, A.L. Sherratt, S.M. Lee, R.J. Smith, C. Senner, J. Hinds, K. Rajakumar, R.A. Adegbola, and G.S. Besra Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum PLoS Med 5 4 2008 e75